Today we’d like to introduce you to Todd Applebaum.
Todd, please share your story with us. How did you get to where you are today?
With early experience working in operations in the automotive and industrial sectors, I began consulting in the manufacturing practice of Deloitte Consulting in Boston, while in Boston I became increasingly fascinated with the growing biotech and life sciences industry here in the region. I left Deloitte, and through a series of entrepreneurial ventures moved into the industry, first as a consultant, then as an industry analyst and more recently as an executive leading Technical Operations at a local biotech company. I’ve seen firsthand the challenges life science companies face in moving from a focus on scientific innovation to a complementary focus on excellence in commercial and technical operations. Now I’ve formed Converge to bring high quality management and technical consulting services to the life sciences industry, helping clients achieve important business objectives by bridging the gap between sound strategy and reliable execution.
Overall, has it been relatively smooth? If not, what were some of the struggles along the way?
The biotech industry can be very uncertain. Bringing innovative technology to market, these companies face scientific, technical, clinical, regulatory and operational risks. If clinical trials don’t provide positive data. Programs can be cancelled, funding may be constrained and a company’s development can be delayed. On the other hand, strong results, or a positive regulatory decision can dramatically accelerate a firm’s growth. The challenge, then, has been keeping pace with these dynamic companies in a very volatile industry, and adjusting our services to continue to provide value in fast changing business conditions.
Alright – so let’s talk business. Tell us about Converge Consulting – what should we know?
Converge Consulting is a business consulting firm exclusively serving the life sciences industry. We focus on helping clients achieve important business objectives by bridging the gap between sound strategy and reliable execution. Clients benefit from the experience and capabilities of our practitioners, direct interaction with our senior team, our commitment to delivering superior service and exceeding our clients’ expectations.
Biopharmaceutical firms are faced with an array of challenges as they commercialize their drug discoveries. Daunting technical challenges, complex and evolving regulatory requirements, and the need to invest significant capital before the success of a drug is in-hand dramatically raise the level of internal risk. Adding to the challenge is the inherently multidisciplinary array of skills required to commercialize biopharmaceuticals.
For many advanced therapies, variability in operations and performance can hinder the ability to bring product to market. Biopharmaceutical firms face constraints in critical production capacity, skilled resources and financial capital, all of which can have a great impact on compliance and limit the company’s ability to capitalize on commercial opportunities.
Successful development, launch, and sustainable supply depend upon bridging knowledge and skills across corporate functions. Groups as varied as Process Development, Quality, Manufacturing, Materials Sourcing, Marketing, and Finance must work together as a team. We work with your organization to design and manage critical processes the way work is actually performed – across traditional functional boundaries, and across the supply network.
Converge is dedicated to helping clients turn business strategies into effective operational processes. While you focus on your core capabilities of scientific and technical excellence, we can help you develop and implement effective strategies and methods to bring product to market, ensure supply, maintain compliance, scale the business, and accelerate growth.
Additionally, the effective management of operations over and above GMP requirements, in areas such as Manufacturing (CMC), Supply Planning, Materials Management, Tech Transfer and Change Control is crucial to meeting milestones and ensuring quality. These techniques can also increase organizational flexibility, and support a collaborative culture that allows your organization to scale.
It is not so much the quality of your strategies but rather your execution that ultimately generates value. The key is to ensure that operations stay tightly aligned with your business strategies, even as those strategies continue to evolve. We keep your team focused on managing and improving execution over time in areas that are crucial to the achievement of those strategies. A focus on Operational Excellence builds value by enhancing your ability to execute, enabling you to compete more quickly, ensuring agility in the face of uncertainty, and ultimately accelerating both revenue and profitability.
Any shoutouts? Who else deserves credit in this story – who has played a meaningful role?
My family deserves a great deal of credit, for being supportive and helping me get some of the initial startup work done behind the scenes.
Contact Info:
- Website: www.convergeconsulting.com
- Phone: 857-362-8925
- Email: Tapplebaum@convergeconsulting.com
Getting in touch: BostonVoyager is built on recommendations from the community; it’s how we uncover hidden gems, so if you know someone who deserves recognition please let us know here.
